Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMhp Reg S Regulatory News (MHPC)

Share Price Information for Mhp Reg S (MHPC)

Share Price is delayed by 15 minutes
Get Live Data
8.58    -0.12 (-1.38%)
Bid:
8.56
Ask:
8.78
Spread: 0.22 (2.57%)
Market Cap: $918.39m
MHPC Live PriceLast checked at - London Stock Exchange

Intraday Mhp Reg S Share Chart

  • This share is an international stock.

Amendments to the Deposit Agreement

18 Sep 2017 09:30

RNS Number : 0179R
MHP S.E.
18 September 2017
 

 

PRESS RELEASE

18 September, 2017, Kyiv, Ukraine

MHP SE

Amendments to the Deposit Agreement

MHP SE, a European Public Limited Liability Company ("SE") with registered office at 5, rue Guillaume Kroll, L-1882 Luxembourg, Grand Duchy of Luxembourg (the "Company"), belonging to one of the leading agro-industrial group in Ukraine, announces that on 14 of September 2017, a supplemental agreement amending a Deposit Agreement dated 14 May 2008 between the Bank of New York Mellon, as depositary (the "Depositary") and the Company (the "Deposit Agreement"), was executed (the "Supplemental Agreement"). The Supplemental Agreement provides for the amendments to the terms and conditions of the global depositary receipts representing registered ordinary shares of the Company ("GDRs") as set out in Schedule 1 of the Deposit Agreement and the Master GDRs (the "Existing Conditions").

At the time of entry into the Deposit Agreement, the name of the Company was MHP S.A., and it was a Luxembourg public limited liability company (société anonyme) with registration number R.C.S. Luxembourg B 116 838. On 7 August 2017, MHP S.A. was converted into MHP SE, a European Public Limited Liability Company (Societas Europaea) incorporated under Council Regulation (EC) No 2157/2001 of 8 October 2001 on the Statute for a European Company (SE) (an "SE Company") and under the laws of the Grand Duchy of Luxembourg, and registered with the Luxembourg Trade and Companies Register (R.C.S. Luxembourg) under number B116838. As MHP SE intends to change its place of domicile from the Grand Duchy of Luxembourg to the Republic of Cyprus, the Supplemental Agreement provided for amendments to the Deposit Agreement and the Existing Conditions (the "Amendments").

The Amendments include various updates to the Existing Conditions, including amendments to reflect the fact that the registered office of the Company will be transferred from Luxembourg to Cyprus.

 

The Amendments take effect on the date on which the Registrar of Companies in Cyprus registers the Company in the Cyprus registry for SE Companies.

 

Note: "The European Union Market Abuse Regulation EU 596/2014 requires MHP SE to disclose that this announcement contains inside information, as defined in that Regulation."  

 

Please address any questions or concerns to:

Anastasiia Sobotiuk (Kyiv)

Director of IR & Company Secretary

 

+38 044 207 00 70

+38 050 339 29 99

a.sobotyuk@mhp.com.ua

John Grant (London)

Senior Independent Director

+44 (0)7768 465042

johngrant13@btconnect.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFASAAFWSEEU
Date   Source Headline
16th Jun 20267:37 amRNSQ1 2026 Financial Results Announcement
1st Jun 20267:00 amRNSMHP SE to acquire up to 100% of Th. Nitsiakos AVEE
8th May 20267:34 amRNSMHP SE Notice of Annual General Meeting
5th May 20267:04 amRNSFinancial Results for the Q4 and 12M
17th Feb 20261:10 pmRNSMHP 2026 NOTES REDEMPTION PRICE ANNOUNCEMENT
13th Feb 20269:34 amRNSMHP LUX S.A. ANNOUNCES RESULTS OF TENDER OFFER
10th Feb 202610:32 amRNSMHP SE TAP OFFERING CLOSING ANNOUNCEMENT
4th Feb 20267:00 amRNSMHP Tap Pricing Announcement
3rd Feb 20269:11 amRNSMHP Tap Launch Announcement
28th Jan 202611:21 amRNSMHP NEW EUROBOND CLOSING ANNOUNCEMENT
22nd Jan 20267:00 amRNSMHP SE - Eurobond 2026 - Pricing Announcement
15th Jan 20261:28 pmRNSMHP 2026 NOTES CONDITIONAL REDEMPTION ANNOUNCEMENT
15th Jan 20261:12 pmRNSMHP SE NEW EUROBOND MANDATE AND TENDER OFFER
15th Jan 202612:57 pmRNSMHP LUX S.A. - INVITATION TO PURCHASE NOTES
15th Dec 20257:00 amRNSMHP SE Financial Results for the Q3 and 9 M 2025
9th Dec 20252:07 pmRNSMHP SE Results of EGM 09 December 2025
14th Nov 20252:14 pmRNSNotification about GDRs Purchase by PDMR of MHP
7th Nov 20258:25 amRNSConvening Notice of Extraordinary General Meeting
12th Sep 20257:00 amRNSFinancial Results for the Q2 and 6M 2025
4th Aug 20257:00 amRNSMHP Closes Acquisition of 92% Stake in Grupo UVESA
16th Jun 20251:39 pmRNSMHP SE Results of AGM 2025
21st May 20257:00 amRNSFinancial Results for the First Quarter 2025
14th May 20258:58 amRNSNotice of Annual General Meeting 2025
28th Apr 20257:09 amRNSFinancial Results Q4 and 12M 2024
28th Apr 20257:00 amRNSMHP acquires 91.77% of UVESA
21st Mar 20257:00 amRNSMHP signs Share Purchase Agreement with UVESA
11th Dec 20247:00 amRNSMHP offers to acquire UVESA Group
10th Dec 20241:08 pmRNSPress release on EGM result
22nd Nov 20247:10 amRNSFinancial Results for Q3 and 9M 2024
5th Nov 202411:33 amRNSNotice of Extraordinary General Meeting
17th Sep 202412:31 pmRNSDisclosure Notification
6th Sep 20249:29 amRNSFinancial Results for Q2 and 6M 2024 replace
19th Jun 202410:34 amRNSResults of AGM
4th Jun 20247:37 amRNSFinancial Results for the First Quarter 2024
17th May 20248:47 amRNSConvening Notice - AGM 2024
17th May 20247:22 amRNSBoard Changes
10th May 20247:58 amRNS2024 Eurobond Repayment
2nd May 20247:30 amRNS2023 Integrated Annual Report and Press Statement
11th Mar 20241:02 pmRNSEGM Results
7th Feb 202412:41 pmRNSEGM- Convening Notice
23rd Jan 20249:54 amRNSAppointment of a new ARC Chair
16th Nov 20237:13 amRNSQ3 and 9M 2023 Financial Results
25th Sep 20239:02 amRNSFinancial Statement Q2 2023
21st Sep 20237:06 amRNSDate Notification Q2 2023 Results
8th Sep 20237:00 amRNSMHP SE Invests in Saudi Arabia
19th Jun 20238:41 amRNSAGM results
18th May 20237:00 amRNSQ1 2023 Financial and Operational Results
17th May 202311:00 amRNSAGM Convening Notice
11th Apr 20239:42 amRNSMHP SE Standalone FS 2022
11th Apr 20239:27 amRNSMHP SE Standalone FS 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.